Status:
COMPLETED
Immediate Versus Delayed Natural Cycle Frozen Embryo Transfers
Lead Sponsor:
Antalya IVF
Conditions:
Clinical Pregnancy
Eligibility:
All Genders
18-40 years
Brief Summary
Introduction: Based on recent studies the suggestion is that natural cycle frozen embryo transfers (NC FET) should preferably be used, with evidence suggesting that artificial cycle FET (AC FET) is s...
Detailed Description
Introduction The increasing success of frozen embryo transfers (FET) in assisted reproductive technology (ART), and, therefore, the increasing use of FET to overcome standard IVF complications (i.e., ...
Eligibility Criteria
Inclusion
- Patients with female age 18≤40 years.
- Patients who provide written informed consent to participate in the trial and for the use of their anonymized data in research.
- Patients with \<2 previous IVF treatments.
- Patients with ≥1 blastocyst cryopreserved.
Exclusion
- Patients with female age \>40 years
- Patients with female BMI ≥30 kg/m2.
- Female patients with insulin dependent diabetes or non-insulin dependent diabetes mellitus and female patients with gastrointestinal, cardiovascular, pulmonary, liver or kidney disease.
- Female patients with any contraindications or allergies to the drugs used in routine freeze-all-IVF.
- Patients with untreated intrauterine anomalies and tubal pathology.
- Patients undergoing PGT-A (aneuploidy) or PGT-M (monogenic disorders)
- Patients with no blastocysts cryopreserved.
Key Trial Info
Start Date :
March 4 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 8 2025
Estimated Enrollment :
818 Patients enrolled
Trial Details
Trial ID
NCT05215119
Start Date
March 4 2022
End Date
February 8 2025
Last Update
February 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Antalya IVF
Antalya, Antalya, Turkey (Türkiye), 07080